Abu-Absi Susan reported AURA

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0002148701-26-000008

Machine-readable

Structured copy

Timestamps

Event (reported)

Sep 1, 2026

Published

Sep 1, 2026

Ingested by INSIDER

Nov 5, 02:19 UTC

Last re-read

Nov 5, 02:19 UTC

Extracted facts

Filer

Abu-Absi Susan

Role

Chief Operating Officer

Transaction

Grant or awardAs filed: “A”

Asset

Aura Biosciences, Inc.

Ticker

AURA

Shares

134.5K

Price per share

$0

Execution date (reported)

Sep 1, 2026

Owned after transaction

134.5K shares

Days from execution to publication

0

What this establishes

Abu-Absi Susan filed this Form 4 reporting a grant or award of AURA on Sep 1, 2026. It became public on Sep 1, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Chief Operating Officer

Abu-Absi Susancik:0002148701

Issuer

Aura Biosciences, Inc.cik:0001501796

Revision history · 0

No field has changed since this record was first ingested.